An open, randomized, single-center study assessing the serum time-concentration curves and the effect of prophylactic moxifloxacin (in comparison with cefuroxime) on the early inflammatory response to cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.
Phase of Trial: Phase IV
Latest Information Update: 03 Oct 2011
At a glance
- Drugs Cefuroxime; Moxifloxacin
- Indications Bacterial infections; Postoperative infections
- Focus Therapeutic Use
- 11 Jun 2011 New trial record